White House trade adviser Peter Navarro is leading a Trump administration effort to demand the Food and Drug Administration reverse course and grant a second emergency authorization for the antimalarial drug hydroxychloroquine to treat covid-19, the disease caused by the coronavirus.
Navarro, armed with a controversial new study that he says shows the drug’s effectiveness, is being cheered on by President Trump, who has long touted the drug as a “game changer” and even used himself as a possible preventive measure. Trump praised the study on Twitter earlier this week, urging the FDA to “Act Now.” The campaign also has been promoted by Rudolph W. Giuliani, the president’s lawyer, and Laura Ingraham’s show on Fox News.